Premium
Processa Pharmaceuticals Inc (PCSA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Dr. David YoungCo-Founder, President of Research and Development & Director | 1,79k | 4,59k | Achat | 2,57 | 17,56k | 11,32% |
| 2026-05-29 | Mr. Russell L. SkibstedCFO | 2,29k | 5,89k | Achat | 2,57 | 10,76k | 27,07% |
| 2026-05-29 | Mr. George K. NgCEO & Director | 2,13k | 5,47k | Achat | 2,57 | 14,26k | 17,55% |
| 2026-05-29 | Mr. Patrick LinCo-Founder, Chief Business & Strategy Officer | 1,58k | 4,07k | Achat | 2,57 | 10,92k | 16,95% |
| 2026-05-29 | Ms. Wendy J. GuyCo-Founder, Chief Administrative Officer & Corporate Secretary | 1,83k | 4,70k | Achat | 2,57 | 10,17k | 21,92% |
| 2026-05-15 | Mr. George K. NgCEO & Director | 1,84k | 5,47k | Achat | 2,97 | 12,13k | 17,92% |
| 2026-05-15 | Dr. David YoungCo-Founder, President of Research and Development & Director | 1,55k | 4,59k | Achat | 2,97 | 15,78k | 10,86% |
| 2026-05-15 | Mr. Patrick LinCo-Founder, Chief Business & Strategy Officer | 1,37k | 4,07k | Achat | 2,97 | 9,33k | 17,19% |
| 2026-05-15 | Ms. Wendy J. GuyCo-Founder, Chief Administrative Officer & Corporate Secretary | 1,58k | 4,70k | Achat | 2,97 | 8,01k | 24,63% |
| 2026-05-15 | Mr. Russell L. SkibstedCFO | 1,98k | 5,89k | Achat | 2,97 | 8,47k | 30,61% |
| 2026-04-15 | Mr. George K. NgCEO & Director | 1,84k | 5,47k | Achat | 2,97 | 8,27k | 28,69% |
| 2026-04-30 | Dr. Sian E. BigoraCo-Founder and Chief Development & Regulatory Officer | 1,97k | 5,34k | Achat | 2,71 | 7,48k | 35,77% |
| 2026-04-30 | Dr. David YoungCo-Founder, President of Research and Development & Director | 1,71k | 4,59k | Achat | 2,69 | 14,25k | 13,61% |
| 2026-04-30 | Mr. Russell L. SkibstedCFO | 2,19k | 5,89k | Achat | 2,69 | 6,50k | 50,84% |
| 2026-04-30 | Mr. George K. NgCEO & Director | 2,03k | 5,47k | Achat | 2,69 | 10,30k | 24,60% |
| 2026-04-30 | Ms. Wendy J. GuyCo-Founder, Chief Administrative Officer & Corporate Secretary | 1,75k | 4,70k | Achat | 2,69 | 6,44k | 37,25% |
| 2026-04-30 | Mr. Patrick LinCo-Founder, Chief Business & Strategy Officer | 1,51k | 4,06k | Achat | 2,69 | 7,98k | 23,37% |
| 2026-04-15 | Dr. David YoungCo-Founder, President of Research and Development & Director | 1,55k | 4,59k | Achat | 2,97 | 12,54k | 14,05% |
| 2026-04-15 | Mr. Patrick LinCo-Founder, Chief Business & Strategy Officer | 1,37k | 4,07k | Achat | 2,97 | 6,47k | 26,86% |
| 2026-04-15 | Ms. Wendy J. GuyCo-Founder, Chief Administrative Officer & Corporate Secretary | 1,58k | 4,70k | Achat | 2,97 | 4,69k | 50,90% |
| 2026-04-15 | Dr. Sian E. BigoraCo-Founder and Chief Development & Regulatory Officer | 1,80k | 5,34k | Achat | 2,97 | 5,51k | 48,48% |
| 2026-04-15 | Mr. Russell L. SkibstedCFO | 1,98k | 5,89k | Achat | 2,97 | 4,31k | 85,37% |
| 2026-03-31 | Mr. James R. NealIndependent Director | 789,00 | 2,00k | Achat | 2,54 | 818,00 | 2 720,69% |
| 2026-03-31 | Dr. David YoungCo-Founder, President of Research and Development & Director | 1,81k | 4,59k | Achat | 2,54 | 10,99k | 19,71% |
| 2026-03-31 | Mr. Russell L. SkibstedCFO | 2,32k | 5,89k | Achat | 2,54 | 2,32k | - |
| 2026-03-31 | Ms. Geraldine Liu PannuIndependent Director | 2,07k | 5,25k | Achat | 2,54 | 2,19k | 1 786,21% |
| 2026-03-31 | Mr. Patrick LinCo-Founder, Chief Business & Strategy Officer | 1,60k | 4,06k | Achat | 2,54 | 5,10k | 45,89% |
| 2026-03-31 | Ms. Wendy J. GuyCo-Founder, Chief Administrative Officer & Corporate Secretary | 1,85k | 4,70k | Achat | 2,54 | 3,11k | 147,61% |
| 2026-03-31 | Dr. Sian E. BigoraCo-Founder and Chief Development & Regulatory Officer | 2,11k | 5,34k | Achat | 2,54 | 3,71k | 131,36% |
| 2026-03-31 | Mr. Khoso BaluchIndependent Director | 2,27k | 5,75k | Achat | 2,54 | 2,33k | 4 051,79% |
| 2026-02-13 | HX Entertainment LimitedSociété | 86,96k | 200,00k | Achat | 2,30 | 305,64k | 39,76% |
| 2026-01-01 | Dr. David YoungCo-Founder, President of Research and Development & Director | 49,00 | 0,00 | Derivative Exercise and Retained Stock | - | 9,18k | 0,54% |
| 2026-01-01 | Mr. Patrick LinCo-Founder, Chief Business & Strategy Officer | 193,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,49k | 5,85% |
| 2026-01-01 | Ms. Wendy J. GuyCo-Founder, Chief Administrative Officer & Corporate Secretary | 193,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,26k | 18,16% |
| 2026-01-01 | Dr. Sian E. BigoraCo-Founder and Chief Development & Regulatory Officer | 249,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,60k | 18,38% |
| 2025-08-04 | HX Entertainment LimitedSociété | 218,69k | 1,24M | Achat | 5,69 | 218,69k | - |
| 2025-08-04 | HX Entertainment LimitedSociété | 218,69k | 1,24M | Achat | 5,69 | 218,69k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
